LGALS2 and cancer: studies so far suggest that galectin-2 expression and secretion may contribute to enhancing the mucosal barrier of the gastrointestinal tract and be involved in regulation of the pathogenesis of coronary artery diseases, rheumatoid arthritis, cancer, and pregnancy disorders.